12/16
04:05 pm
fblg
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Medium
Report
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/15
08:00 am
fblg
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/10
09:19 am
fblg
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions [Yahoo! Finance]
Medium
Report
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions [Yahoo! Finance]
12/10
08:30 am
fblg
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
Medium
Report
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
11/26
08:30 am
fblg
FibroBiologics Announces Payoff of Outstanding Debt
Low
Report
FibroBiologics Announces Payoff of Outstanding Debt
11/25
04:56 pm
fblg
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Low
Report
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
11/25
04:05 pm
fblg
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Low
Report
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/24
09:00 am
fblg
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/20
08:22 am
fblg
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Medium
Report
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
11/20
08:00 am
fblg
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
Medium
Report
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
11/19
07:03 pm
fblg
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Low
Report
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/19
08:36 am
fblg
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/5
07:19 am
fblg
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/3
08:03 am
fblg
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Low
Report
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
10/31
04:53 pm
fblg
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
10/31
04:30 pm
fblg
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/24
08:30 am
fblg
FibroBiologics to Present at Bio-Europe 2025
Medium
Report
FibroBiologics to Present at Bio-Europe 2025
10/14
08:30 am
fblg
FibroBiologics to Present at the 2025 ThinkEquity Conference
Low
Report
FibroBiologics to Present at the 2025 ThinkEquity Conference